Reaching out to the world
Unichem’s foray into the Americas encompasses the US, Canada, Brazil and other Latin American markets.
As a cornerstone of its strategy for the United States, Unichem has made significant progress by marketing a growing list of US FDA approved products through its wholly-owned subsidiary, Unichem Pharmaceuticals (USA), Inc. Unichem is aspiring to become a major player in the US market by offering high quality and cost-effective generic products. The majority of the company’s products are vertically integrated.
The company has several US FDA approved Abbreviated New Drug Applications (ANDAs) and continue to file new Drug Master Files (DMFs) and ANDAs for US FDA approval and launch in the US market. Unichem’s R&D team in Goa (India) is actively developing a robust pipeline of Active Pharmaceutical Ingredients (APIs) and ANDAs to support our ambitious growth plans.
Unichem has product development and supply agreements with the leading Canadian generic companies.
Unichem’s wholly owned subsidiary company, Unichem Farmaceutica do Brasil Ltda., will focus on the growing demand for generic products in the Brazilian pharmaceutical market. The company is currently marketing several ANVISA approved products in Brazil. The company is filing many new products dossiers for ANVISA approval and there are several more in the company’s development pipeline. Unichem is set to aggressively develop and grow its business in Brazil.
Unichem has also formed distribution and marketing alliances with key players in other Latin American markets.